Objective: A treatment dilemma exists when finding positive surgical margins after radical prostatectomy. Our aim is to better understand the effect of positive surgical margins (PSM) on biochemical recurrence and differences between delayed vs immediate treatment after radical prostatectomy.
Introduction
Prostate cancer is the most common cancer found in men and the second leading cause of cancer death in men. The American Cancer Society estimates there will be nearly 233,000 new cases and 29,480 deaths from prostate cancer in the US in 2015. 1 American men have a 1 in 7 chance of being diagnosed with prostate cancer, and a 1 in 36 chance of dying from prostate cancer. 1 Additionally, the costs associated with prostate cancer will approach $18 million by the end of the decade and the prevalence of prostate cancer will increase by 40% from 2010 to 2020. 2 Due to the prevalence of prostate cancer and its associated costs, a number of randomized controlled trials have examined different treatment methods for prostate cancer; specifically, radical prostatectomy and radiation therapy.
Radical prostatectomy (RP) is the gold standard of treatment for localized prostate cancer. This treatment can be performed open, laparoscopic or robotic in otherwise healthy patients and produces the most accurate staging of the cancer.
Additionally, a radical prostatectomy has the highest likelihood to cure the disease. 8 However, 6.5 -32% of radical prostatectomy surgeries have a positive surgical margin (PSM). 3 PSM's are associated with an increased risk for biochemical recurrence (BCR) which is indicated by a PSA level greater than 0.2 ng/mL. However, the percentage of men that will actually have a BCR who had positive surgical margins post operatively is relatively low, ranging from 16.6-40%. [4] [5] Additionally, PSM'S provoke anxiety in men because they live with a greater fear of cancer recurrence than those without PSMs. 6 When faced with a positive surgical margin after surgery, urologists and patients are faced with a treatment dilemma. The choices are to immediately treat with adjuvant therapy such as radiation or to wait and monitor for a BCR. There is a lack of evidence that PSMs increase the risk of prostate specific mortality and it has been found that long-term outcomes are similar between patients who had adjuvant radiation therapy and recurrence versus those who had salvage radiation therapy following BCR. [4] [5] Furthermore, Schroeck et al found that there is a wide variability in how urologists manage the treatment of prostate cancer across the United States. 7 A lack of clear evidence of a benefit makes the decision to treat for PSM more perplexing.
In work by Yossepowitch and colleagues, they found that for the patients with a positive surgical margin, radiation therapy (RT) is the only established treatment with cure potential. The authors concluded that a randomized trial in patients with positive surgical margin comparing immediate postoperative radiation therapy to salvage radiation therapy is critically needed before definitive recommendations can be made. 8 This study investigated oncologic outcomes after radical prostatectomy with a positive surgical margin of those who did not have immediate radiation. We investigated whether or not a positive surgical margin had an impact on biochemical recurrence and also the overall outcome after the radical prostatectomy. Our primary focus was to determine if not treating immediately is an appropriate treatment option for prostate cancer patients with positive surgical margins to maintain excellent oncologic outcomes, as well as maintaining good quality of life by avoiding adjuvant XRT.
Methods
This study is a case series of patients with a positive surgical margin after radical prostatectomy that did not receive immediate radiation treatment. All patients who had a radical prostatectomy during January 1, 2000 through June 1, 2010 were included in our sample. Our inclusion criteria were "any patient that had a radical prostatectomy and a positive surgical margin that did not receive immediate radiation treatment." Our exclusion criteria were "any patients with a negative surgical margin or in-adequate follow up and those patients who received adjuvant therapy prior to or right after RP." Data were obtained from our locally maintained Tumor Registry and available medical records. Data collected included: Name, age, date of diagnosis of prostate cancer, date of surgery, surgical approach, length of hospital stay, complications within 30 days, PSA labs prior to and after surgery, Gleason score pre-surgery and post surgery, blood loss, margin status (-/+) and length of margin, location of margin, date of biochemical recurrence (PSA >0.2), date of metastasis, date of death. A descriptive analysis was performed with means, standard deviations, ranges and percentages being reported for the respective variables. In addition, subgroup analysis was conducted using the different surgical methods to examine outcomes. Continuous variables were analyzed using the Student's t-test and categorical variables using Fisher's Exact Test. Logistic regression was used to determine if any variables were associated with a biochemical recurrence. A p-value < 0.05 was considered statistically significant.
Results
A close review of men who had undergone radical prostatectomy during the period of January 2000 through December 2010 was performed. Only those men who had a positive surgical margin on pathology report and did not receive immediate radiation treatment were included in the data analysis (Table 1) . Fifty-one subjects were found to have positive surgical margin without immediate treatment out of 468 patients who underwent radical prostatectomy, which equates to 11% positive margin rate (Figure 1 ). In the group without immediate external radiation therapy (XRT), 13 (25%) had experienced BCR while 38(75%) had no BCR of prostate cancer (Table 2) . Of these 13, 6 received salvage radiation therapy and at the time of this study, 5 continue to have PSA levels ≤ 0.2 ( Table 3) . Analysis of location and staging of these 13 men with BCR determined that 9 (70%) had multifocal PSM and 8 (62%) were staged as T3/T4 (Table 2 ). Median follow-up was 46.9 months with a mean follow-up of 61 months. Logistic regression analysis did not identify any associations between variables and biochemical recurrence. 
Discussion
Radical prostatectomy is one treatment option for prostate cancer with localized disease in an otherwise healthy patient. However, in 6.5 -32% of radical prostatectomy surgeries a positive surgical margin is found. 3 This has been consistent across the surgical approaches for radical prostatectomy (open vs. laparoscopic vs. robotic assisted laparoscopic). 3, 9 Some risks that can increase the likelihood of a positive surgical margin include pathologic stage (pT2 and higher), preoperative PSA level, tumor volume, increased BMI, and surgeon experience. 3, 9, 10 Positive surgical margins following radical prostatectomy are known to be an unfavorable prognostic factor in prostate cancer. PSMs are associated with an increase in biochemical recurrence and local disease recurrence. 8, [11] [12] [13] [14] Wiegel et al have shown that patients treated with adjuvant radiation therapy had a higher percentage of progression free survival versus those who had a wait and see treatment approach (56% vs. 35%). However, they also concluded that adjuvant radiation therapy does not improve metastasis free survival and overall survival. 15 In addition, adjuvant radiation after RP poses significant risks of side effects and its use is debated frequently.
Radiation therapy can be associated with significant morbidity including erectile dysfunction, radiation cystitis, radiation proctitis, urinary incontinence, fecal incontinence, rectal bleeding, bladder hemorrhage, hospitalizations for treatment-related complications, and secondary primary malignancies including bladder cancer. [16] [17] [18] [19] [20] Even with studies showing that PSMs increase the risk of biochemical recurrence, 60%-75% of contemporary patients with PSMs are cured by radical prostatectomy alone. 4 This indicates that the majority of patients with PSM's after radical prostatectomy will never have a BCR. Kang et al. found the rates of BCR in high risk patients, including PSMs after radical prostatectomy, are 16.6% which is much lower than previous studies have suggested. Kang's study raised the concern that men who fall into the high risk category are being over treated with adjuvant radiation therapy and unnecessarily suffer the morbidity associated with radiation therapy. 5 Additionally, there is a lack of evidence that PSMs increase risk of prostate specific mortality and it has been found that long-term outcomes are similar between patients who had adjuvant radiation therapy and recurred versus those who had salvage radiation therapy following BCR. [4] [5] The most striking finding from our study was that with a mean follow-up of 61 months, 38 (75%) patients who did not receive immediate radiation were biochemically cancer free. This indicates they were able to avoid the previously listed side effects of radiation, yet still have a low chance of biochemical recurrence. These findings support the work by Kang et al. who looked at high risk patients in terms of likelihood of BCR.
Our study included all risk groups and found that BCR was unlikely in the 5 years after prostatectomy with a PSM. We are concerned that men with positive surgical margins regardless of risk category are being over treated with immediate radiation at the cost of significant morbidity with little gain in oncologic outcome. Radiation should still be considered in those men at high risk of recurrence such as those with seminal vesicle invasion, high-risk disease, and high risk features in younger, healthy men.
Some limitations of this study include the small sample size and the retrospective nature of the study. Although these groups are small, the concern for overtreatment is real.
Conclusion
Salvage radiation at the time of biochemical recurrence may spare some men the side effects of immediate radiation with acceptable risk of treatment success. Most men with a positive surgical margin will not have a recurrence in the first 5 years and can likely be salvaged with radiation when they do. In an era where treatment of prostate cancer includes active surveillance, consideration of surveillance after surgery with a positive margin should be encouraged. A larger sample size and longer follow up is necessary to support these conclusions.
